2023-05-08 12:31:43 ET
- Assertio Therapeutics ( NASDAQ: ASRT ) is scheduled to announce Q1 earnings results on Tuesday, May 9th, before market open.
- The consensus EPS Estimate is $0.22 (-42.1% Y/Y) and the consensus Revenue Estimate is $37.64M (+3.0% Y/Y).
- Over the last 2 years, ASRT has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 2 upward revisions and 1 downward.
For further details see:
Assertio Therapeutics Q1 2023 Earnings Preview